Ly-49-independent inhibition of NK cell-mediated cytotoxicity by a soluble MHC class I molecule
ORCiD
David M. Ojcius: 0000-0003-1461-4495
Department
Biomedical Sciences
Document Type
Article
Publication Title
European Journal of Immunology
ISSN
0014-2980
Volume
24
Issue
9
DOI
10.1002/eji.1830240927
First Page
2110
Last Page
2114
Publication Date
9-1-1994
Abstract
Natural killer (NK) cells lyse their targets in a non-major histocompatibility complex (MHC)-restricted manner, and the cytotoxicity can be inhibited by a number of MHC class I allele products, suggesting that NK cells may have a “positive receptor” that recognizes the target and a “negative receptort” that receives an inhibitory signal from class I. Since negative receptors could also exert their effect by masking a positive ligand, we have determined whether there may be a direct interaction between class I and an NK surface receptor by measuring cytotoxicity in the presence of a soluble class I molecule, Kd. Soluble Kd at micromolar concentrations could efficiently block NK cell cytotoxicity, suggesting that class I has a direct effect on cytotoxicity, rather than masking another target cell ligand. Inhibition required that Kd be at least divalent, probably because of its higher affinity or its ability to cross-link the NK surface receptor. In addition, the effect was independent of the peptide used to load Kd, and there was inhibition of cytotoxicity of NK cells derived from either H-2d or H-2b mice. Finally, depletion of NK cells expressing Ly-49 had no effect on the specific inhibition by Kd, raising the possibility that NK cells are endowed with additional negative receptors besides Ly-49. Taken together, these results suggest that there may be a family of NK receptors recognizing different class I alleles, which can receive negative signals by directly binding to class I on the target cell surface.
Recommended Citation
Roth, C.,
Kourilsky, P.,
&
Ojcius, D. M.
(1994).
Ly-49-independent inhibition of NK cell-mediated cytotoxicity by a soluble MHC class I molecule.
European Journal of Immunology, 24(9), 2110–2114.
DOI: 10.1002/eji.1830240927
https://scholarlycommons.pacific.edu/dugoni-facarticles/203